ArticleOncology letters2026

MAD2L1 overexpression promotes breast cancer progression and confers resistance to paclitaxel via proteasomal stabilization.

Shih-Ho Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.